About MACROGENICS, INC.
MacroGenics is a clinical-stage biopharmaceutical company focused on developing innovative, next-generation antibody-based therapies to improve the lives of cancer patients. The company is advancing a broad pipeline of novel product candidates incorporating proprietary technology platforms.
Developing next-generation antibody-based therapiesAdvancing a broad pipeline of novel product candidatesLeveraging platform technologies including antibody-drug conjugates (ADCs), bispecific checkpoint antibodies, and next-generation T-cell engagers
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| IGF::OT::IGF DUAL AFFINITY RE-TARGETING MOLECULES FOR HIV-1 SUPPRESSION | Department of Health and Human Services | $25.1M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MACROGENICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.